Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD22 | P20273 | 15/20 | 0.36 |
| ▸ | NANP | Q8TBE9 | 1/20 | 0.33 |
| ▸ | MAG | P20916 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14454530 | 0.91 | NANP (0.43) | CD22NANP | |
| SCHEMBL12341474 | 0.89 | CD22 (0.37) | CD22 | |
| SCHEMBL12341465 | 0.88 | CD22 (0.35) | CD22NANPMAG | |
| SCHEMBL12341461 | 0.88 | CD22 (0.39) | CD22NANPMAG | |
| SCHEMBL13931893 | 0.87 | NANP (0.39) | CD22NANP | |
| SCHEMBL13948848 | 0.85 | CD22 (0.36) | CD22 | |
| SCHEMBL13402334 | 0.85 | CD22 (0.38) | CD22NANPMAG | |
| SCHEMBL13948845 | 0.85 | CD22 (0.34) | CD22NANPMAG | |
| SCHEMBL10260947 | 0.83 | CD22 (0.35) | CD22MAG | |
| SCHEMBL17083472 | 0.82 | CD22 (0.34) | CD22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9187546-B2 | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants | NOVO NORDISK A/S (DK) | 2015-11-17 | — | — | US | disclosed |
| US-20090124544-A1 | COMPOSITIONS AND METHODS FOR THE PREPARATION OF PROTEASE RESISTANT HUMAN GROWTH HORMONE GLYCOSYLATION MUTANTS | NEOSE TECHNOLOGIES ,INC. A DELAWARE CORPORATION | 2009-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124544-A1 | COMPOSITIONS AND METHODS FOR THE PREPARATION OF PROTEASE RESISTANT HUMAN GROWTH HORMONE GLYCOSYLATION MUTANTS | GHITM, PTMS, GHRHR | CD22 2233/4885NANP 386/4885MAG 1324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.